Content deleted Content added
removed no longer needed PBB controls and templates; expanded with public ___domain NLM content |
→Therapeutic applications: + section heading |
||
Line 20:
The drug [[eculizumab]] prevents cleavage of C5 into C5a and C5b.<ref>{{cite journal | title=Eculizumab| author=Dubois E, Cohen A| journal=Br J Clin Pharmacol| year=2009| volume=68| pages=318–319| pmc=2766470 |doi=10.1111/j.1365-2125.2009.03491.x}}</ref>
== Complement system pathway ==
[[Image:Formowanie MAC.svg|thumb|left|400px|Membrane attack complex. Some labels are in Polish.]]
{{-}}
==References==
{{Reflist}}
| |||